feed,title,long_url,short_url
MedRxiv,Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines,https://medrxiv.org/cgi/content/short/2022.12.02.22282931v1?rss=1,https://bit.ly/3OZESIn
MedRxiv,Analysis of the ARTIC V4 and V4.1 SARS-CoV-2 primers and their impact on the detection of Omicron BA.1 and BA.2 lineage defining mutations,https://medrxiv.org/cgi/content/short/2022.12.01.22282842v1?rss=1,https://bit.ly/3OVbtix
